EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data

Jinghang Jiang iD, Zhongyuan Chen, Honghong Wang, Yifu Wang, Jie Zheng, Yi Guo, Yonghua Jiang, Zengnan Mo

Biomolecules · 2023

DOI: 10.3390/biom13040685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Jinghang Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: Early Detection of Cancer, Ovarian Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Guangxi, Major Project of Guangxi Innovation Driven, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related proteins and develop a new protein prognostic signature for patients with ovarian cancer to predict their prognosis. Patients were brought together in subgroups using a consensus clustering analysis of prognostic-related proteins. To further investigate the role of proteins and protein-coding genes in ovarian cancer, additional analyses were performed using multiple online databases (HPA, Sangerbox, TIMER, cBioPortal, TISCH, and CancerSEA). The final resulting prognosis factors consisted of seven protective factors (P38MAPK, RAB11, FOXO3A, AR, BETACATENIN, Sox2, and IGFRb) and two risk factors (AKT_pS473 and ERCC5), which can be used to construct a prognosis-related protein model. A significant difference in overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) curves were found in the training, testing, and whole sets when analyzing the protein-based risk score (p < 0.05). We also illustrated a wide range of functions, immune checkpoints, and tumor-infiltrating immune cells in prognosis-related protein signatures. Additionally, the protein-coding genes were significantly correlated with each other. EMTAB8107 and GSE154600 single-cell data revealed that the genes were highly expressed. Furthermore, the genes were related to tumor functional states (angiogenesis, invasion, and quiescence). We reported and validated a survivability prediction model for ovarian cancer based on prognostic-related protein signatures. A strong correlation was found between the signatures, tumor-infiltrating immune cells, and immune checkpoints. The protein-coding genes were highly expressed in single-cell RNA and bulk RNA sequencing, correlating with both each other and tumor functional states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerOvarian NeoplasmsHumansFemaleTranscriptomeProteomePrognosisProteomicsBiomarkers, Tumor

Stichwörter der Autor:innen

ovarian cancerproteomesingle celltranscriptometumor-infiltrating immune cells

Substanzen

ProteomeBiomarkers, Tumor

Autor:innen und Institutionen

  • Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China.
  • Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Nanning 530021, China.
  • Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Medical University, Nanning 530021, China.
  • Graduate School, Guangxi Medical University, Nanning 530021, China.
  • Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning 530021, China.
  • School of Public Health, Guangxi Medical University, Nanning 530021, China.

ORCID-Profile: Jinghang Jiang

Förderung

  • Key Research and Development Program of Guangxi
  • Major Project of Guangxi Innovation Driven
  • National Key Research and Development Program of China
  • Natural Key Research and Development Project
  • Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University, Guangxi Key Laboratory for Genomic and Personalized Medicine
  • Scientific Research and Technology Development Plan of Nanning

Zitieren

APA

Jiang, J., Chen, Z., Wang, H., Wang, Y., Zheng, J., Guo, Y., Jiang, Y., & Mo, Z. (2023). Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data. Biomolecules. https://doi.org/10.3390/biom13040685

Vancouver

Jiang J, Chen Z, Wang H, Wang Y, Zheng J, Guo Y, et al. Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data. Biomolecules. 2023. doi:10.3390/biom13040685

BibTeX
@article{Jiang2023,
  author = {Jiang, Jinghang and Chen, Zhongyuan and Wang, Honghong and Wang, Yifu and Zheng, Jie and Guo, Yi and Jiang, Yonghua and Mo, Zengnan},
  title = {Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13040685}
}
Kostenlos starten →